Products

Clenoliximab (TAB-732)

Recombinant chimeric (primate/human) antibody expressed in CHO binding to human CD4/p55. Clenoliximab is a monoclonal antibody against CD4. It acts as an immunomodulator and has been investigated for the treatment of rheumatoid arthritis. The drug is a chimeric antibody from Macaca irus and Homo sapiens.      

  • Datasheet

Specifications
Immunogen
The details of the immunogen for this antibody are not available.
Host
primate
Derivation
Chimeric (primate/human)
Type
IgG4 - lambda
Species Reactivity
Human
Applications
Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods.
Trade name
primatized
CAS NO.
182912-58-9
Generic Name
clenoliximab
Related Disease
Asthma
Target
Alternative Names
clenoliximab; primatized; 182912-58-9; IDEC-151; BB-217969; CD4; CD4 molecule; CD4 antigen (p55) , T cell surface glycoprotein CD4
Entrez Gene ID
920
UniProt ID
P01730

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Verification code

Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Increase Efficiency to Accelerate Your Research & Discovery Process

Increase Efficiency to Accelerate Your Research & 
Discovery Process

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production ...

Find out more >

USA

45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356

Europe

Tel: 44-207-097-1828
Email:
Follow us on:
        

Terms of Service-Privacy Policy     © 2007 - 2019 Creative-Biolabs All Rights Reserved